Eurofins-Cerep SA

Paris Stock Exchange ALECR.PA

Eurofins-Cerep SA Revenue Per Share for the year ending December 31, 2023: USD 9,643.47

Eurofins-Cerep SA Revenue Per Share is USD 9,643.47 for the year ending December 31, 2023, a -4.55% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Eurofins-Cerep SA Revenue Per Share for the year ending December 31, 2022 was USD 10,103.00, a 7.57% change year over year.
  • Eurofins-Cerep SA Revenue Per Share for the year ending December 31, 2021 was USD 9,392.24, a 18.72% change year over year.
  • Eurofins-Cerep SA Revenue Per Share for the year ending December 31, 2020 was USD 7,911.42, a 14.68% change year over year.
  • Eurofins-Cerep SA Revenue Per Share for the year ending December 31, 2019 was USD 6,898.97, a 19.46% change year over year.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
Paris Stock Exchange: ALECR.PA

Eurofins-Cerep SA

CEO Mr. Damien Vielliard
IPO Date April 12, 2000
Location France
Headquarters Le Bois l'Evêque
Employees 209
Sector Health Care
Industries
Pharmaceuticals Biotechnology Research & Consulting
Description

Eurofins Cerep SA provides various drug discovery services to pharmaceutical and biotechnology companies worldwide. The company's research services include compound management, high-throughput screening, in vitro safety profiling, lead optimization (or SAR) profiling, in vitro ADME profiling, and in vivo PK. It also offers assay design and development services. The company was formerly known as Cerep SA and changed its name to Eurofins Cerep SA in June 2014. Eurofins Cerep SA was founded in 1989 and is based in Vienne, France.

StockViz Staff

January 15, 2025

Any question? Send us an email